Literature DB >> 15962219

Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Ville T Peltola1, K Gopal Murti, Jonathan A McCullers.   

Abstract

Secondary bacterial pneumonia is a common cause of death during influenza epidemics. We hypothesized that virus-specific factors could contribute to differences in annual excess mortality. Recombinant influenza viruses with neuraminidases from representative strains from the past 50 years were created and characterized. The specific level of their neuraminidase activity correlated with their ability to support secondary bacterial pneumonia. Recombinant viruses with neuraminidases from 1957 and 1997 influenza strains had the highest level of activity, whereas a virus with the neuraminidase from a 1968 strain had the lowest level of activity. The high level of activity of the neuraminidase from the 1957 strain, compared with that of other neuraminidases, more strongly supported the adherence of Streptococcus pneumoniae and the development of secondary bacterial pneumonia in a mouse model. These data lend support to our hypothesis that the influenza virus neuraminidase contributes to secondary bacterial pneumonia and subsequent excess mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15962219      PMCID: PMC2715995          DOI: 10.1086/430954

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.

Authors: 
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

2.  Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium.

Authors:  H H Tong; M A McIver; L M Fisher; T F DeMaria
Journal:  Microb Pathog       Date:  1999-02       Impact factor: 3.738

3.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae.

Authors:  Jonathan A McCullers; Kimberly C Bartmess
Journal:  J Infect Dis       Date:  2003-03-06       Impact factor: 5.226

4.  Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

Authors:  J J Treanor; F G Hayden; P S Vrooman; R Barbarash; R Bettis; D Riff; S Singh; N Kinnersley; P Ward; R G Mills
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

5.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

6.  Influenza and the winter increase in mortality in the United States, 1959-1999.

Authors:  Thomas A Reichert; Lone Simonsen; Ashutosh Sharma; Scott A Pardo; David S Fedson; Mark A Miller
Journal:  Am J Epidemiol       Date:  2004-09-01       Impact factor: 4.897

7.  Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.

Authors:  Jonathan A McCullers
Journal:  J Infect Dis       Date:  2004-06-30       Impact factor: 5.226

8.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

9.  Update: influenza-associated deaths reported among children aged <18 years--United States, 2003-04 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-01-02       Impact factor: 17.586

10.  Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.

Authors:  G M Air; M C Els; L E Brown; W G Laver; R G Webster
Journal:  Virology       Date:  1985-09       Impact factor: 3.616

View more
  99 in total

1.  The use of antimicrobial agents after diagnosis of viral respiratory tract infections in hospitalized adults: antibiotics or anxiolytics?

Authors:  Kevin T Shiley; Ebbing Lautenbach; Ingi Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

2.  Influenza virus primes mice for pneumonia from Staphylococcus aureus.

Authors:  Amy R Iverson; Kelli L Boyd; Julie L McAuley; Lisa R Plano; Mark E Hart; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

3.  Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza virus subtypes do not affect postinfluenza secondary bacterial pneumonia.

Authors:  Ashok K Chockalingam; Danielle Hickman; Lindomar Pena; Jianqiang Ye; Andrea Ferrero; Jose R Echenique; Hongjun Chen; Troy Sutton; Daniel R Perez
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection.

Authors:  Maria Hedlund; Laura M Aschenbrenner; Kellie Jensen; Jeffrey L Larson; Fang Fang
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

5.  Using a resequencing microarray as a multiple respiratory pathogen detection assay.

Authors:  Baochuan Lin; Kate M Blaney; Anthony P Malanoski; Adam G Ligler; Joel M Schnur; David Metzgar; Kevin L Russell; David A Stenger
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

6.  Bacterial sinusitis and otitis media following influenza virus infection in ferrets.

Authors:  Ville T Peltola; Kelli L Boyd; Julie L McAuley; Jerold E Rehg; Jonathan A McCullers
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.

Authors:  Julie L McAuley; Felicita Hornung; Kelli L Boyd; Amber M Smith; Raelene McKeon; Jack Bennink; Jonathan W Yewdell; Jonathan A McCullers
Journal:  Cell Host Microbe       Date:  2007-10-11       Impact factor: 21.023

Review 8.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 9.  Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.

Authors:  Koenraad F van der Sluijs; Tom van der Poll; René Lutter; Nicole P Juffermans; Marcus J Schultz
Journal:  Crit Care       Date:  2010-04-19       Impact factor: 9.097

10.  Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.

Authors:  Gustavo Palacios; Mady Hornig; Daniel Cisterna; Nazir Savji; Ana Valeria Bussetti; Vishal Kapoor; Jeffrey Hui; Rafal Tokarz; Thomas Briese; Elsa Baumeister; W Ian Lipkin
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.